BTK and neoplasm: Although some studies analyzing BTK inhibition as a possible cancer therapy have proven inconclusive, our present knowledge of BTK signaling within the tumor microenvironment and its effects on tumor progression, coupled with other studies using BTK inhibitors, prompts us to believe that targeting BTK inhibition within the tumor microenvironment may be a novel therapeutic strategy for patients with solid tumors.